Loading clinical trials...
Loading clinical trials...
Evaluation of the Impact of Emotional Skills of Young Women (≤ 45 Years), With Non-metastatic Breast Cancer, and Their Partner on Adjustment to Cancer
The KALICOU 3 study will evaluate the effect of emotional skills of patients and their partners on their individual disease subjective experience during care pathways, from chemotherapy to surveillance.
All women with breast cancer have to face, at any age, to numerous issues linked to cancer (incertitude, recurrence anxiety...) and to physical and psychosocial side effects of treatments which can degrade their life quality. However, young women (\<45 years at diagnostic) have to face specific issues related to their age (early menopause, withdrawal of pregnancy projects, education of young children). Moreover, treatment consequences can alter patient's life quality and can persist in time (fatigue, pains, chemotherapy, sexuality, induced menopause for example). Overall, young patients have a lesser life quality, greater emotional distress and vulnerability and have more difficulties to establish adapted adjustment strategy compared to elder women. The role and importance of relatives, particularly partners, during cancer pathology is incontestable. However, few empiric and consensual data exist on the impact of cancer diagnostic on partners, especially when women are young at initial diagnostic. Nevertheless, available data underline the importance of the supporting partner during breast cancer disease. Cancer also disturbs conjugal relationship. For example, life quality of patient influence strongly the life quality and mental well-being of her partner. Moreover, the intimate relation with the partner could play an important role in healing after breast cancer. Numerous authors underline the importance of focus on the couple instead of patients alone or partners alone with a dyadic approach where dyad member's reactions will be interdependent. Thus, study of dyadic adjustment of couples where a member is facing cancer pathology at young age is indubitably innovative and present a real scientific and clinical interest. More precisely, KALICOU 3 study will focus on the impact of intrapersonal and interpersonal emotional skills of patients and partners on individual and dyadic adjustment.
Age
18 - 45 years
Sex
ALL
Healthy Volunteers
No
ICO-Site Paul Papin
Angers, France
Centre Marie Curie
Arras, France
Institut Sainte Catherine
Avignon, France
Centre Pierre Curie - SCP de radiologie et d'imagerie médicale
Beuvry, France
Polyclinique Bordeaux Nord Aquitaine
Bordeaux, France
CH de BOULOGNE-SUR-MER
Boulogne-sur-Mer, France
Centre François Baclesse
Caen, France
Centre Hôpitalier de Compiègne Noyon
Compiègne, France
Centre Léonard de Vinci
Dechy, France
Centre Georges François Leclerc
Dijon, France
Start Date
July 25, 2016
Primary Completion Date
June 1, 2021
Completion Date
January 1, 2022
Last Updated
March 18, 2026
391
ACTUAL participants
Delivery of questionnaires
OTHER
Questionnaire T1 to fill
BEHAVIORAL
Questionnaire T2 to fill
BEHAVIORAL
Questionnaire T3 to fill
BEHAVIORAL
Questionnaire T4 to fill
BEHAVIORAL
Questionnaire T5 to fill
BEHAVIORAL
Lead Sponsor
Centre Oscar Lambret
Collaborators
NCT05372640
NCT04550494
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions